GF Fund Management’s Praxis Precision Medicines PRAX Stock Holding History

GF Fund Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$166K	Sell	569 -23	-4%	-$7.61K	﹤0.01%	289
2026 Q2	$198K	Buy	592 +30	+5%	+$9.5K	﹤0.01%	275
2026 Q1	$181K	Buy	562 +72	+15%	+$22.3K	﹤0.01%	290
2025 Q4	$144K	Buy	490 +37	+8%	+$6.89K	﹤0.01%	317
2025 Q3	$24K	Sell	453 -24	-5%	-$1.16K	﹤0.01%	470
2025 Q2	$20.1K	Hold	477	–	–	﹤0.01%	503
2025 Q1	$18.1K	Buy	477 +86	+22%	+$5.37K	﹤0.01%	513
2024 Q4	$30.1K	Buy	+391	New	+$28.3K	﹤0.01%	433

Other funds holding PRAX

Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

GF Fund Management's PRAX Position: Q3 2026 in Review

GF Fund Management reduced its Praxis Precision Medicines (PRAX) stake by 3.9% in Q3 2026, selling an estimated $7.61K and leaving 569 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

GF Fund Management first reported a position in PRAX in Q4 2024 and has held it in 8 quarters since. The position peaked at $198K in Q2 2026. 59 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

GF Fund Management held 569 shares of Praxis Precision Medicines worth $166K as of Q3 2026.
GF Fund Management sold 23 Praxis Precision Medicines shares in Q3 2026, an estimated $7.61K.
Praxis Precision Medicines made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #289 holding.
GF Fund Management first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 8 quarters since.
GF Fund Management's Praxis Precision Medicines position peaked at $198K in Q2 2026.
59 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.